News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
We are proud to join with AARP and 35 other orgs to push for competition to lower drug prices – David Mitchell
Photo from David Mitchell/Twitter
Jul 16, 2023, 07:10

We are proud to join with AARP and 35 other orgs to push for competition to lower drug prices – David Mitchell

We are proud to join with AARP and 35 other orgs to push for competition to lower drug prices. We need bipartisan patent & FDA reforms to curb pharma abuse of monopolies and to speed generics and biosimilars to market.

For details: Click here

Source: David Mitchell/Twitter

AARP bipartisan cancer David Mitchell drug FDA generics monopolies OncoDaily Oncology Pharma
Special Coverage
Drugs
Feb 25, 2025, 16:56
Tarlatamab (Imdelltra): What Patients Need to Know About
Science
Feb 25, 2025, 15:10
Wafaa M Rashed: Genomic Innovation for Economic Development
Drugs
Feb 25, 2025, 14:43
Tarlatamab (Imdelltra): Uses in Cancer, Side Effects, Dosages, Expectations, and More
Blog
Feb 25, 2025, 14:12
5 articles suggested by Wafik El-Deiry
Blog
Feb 25, 2025, 14:04
M. Bilal Abid: Concluded the PANAO 2025 conference
Blog
Feb 25, 2025, 13:56
Jasmin Hundal: What Drives Cancer Risk in Adults vs. Children?
Blog
Feb 25, 2025, 13:46
Enrico Pozzo: I will join Humanitas Research Hospital in Milan as staff member
Career
Feb 25, 2025, 13:39
Patrizia Cavazzoni Rejoins Pfizer as Chief Medical Officer and Executive Vice President
Blog
Feb 25, 2025, 13:38
Sean Burroughs: 2025 Funding Rounds and Growing Therapeutic Trends
Blog
Feb 25, 2025, 13:28
Exploratory analysis of biomarkers and histology in DUO-E pMMR - Spanish Gynaecological Cancer Research Group
Science
Feb 25, 2025, 13:26
Partha Basu: 'Screen, triage and treat' vs 'screen and treat' for WLHIV positive on HPV test
Blog
Feb 25, 2025, 11:39
Applonia Rose: Exciting findings on prognostic scoring in metastatic renal cell carcinoma